PMV Pharmaceuticals opens approximately 94% above IPO price and it is stated that the offering was upsized from 7.4M shares to ~11.8M shares and priced at the high-end of the expected range. What's your opinion in this?
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
